SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-003392
Filing Date
2024-05-30
Accepted
2024-05-30 16:50:36
Documents
120
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F betrf_20f.htm   iXBRL 20-F 559816
2 CERTIFICATE OF CHIEF EXECUTIVE OFFICER betrf_ex121.htm EX-12.1 8893
3 CERTIFICATE OF CHIEF FINANCIAL OFFICER betrf_ex122.htm EX-12.2 9660
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER betrf_ex131.htm EX-13.1 4261
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER betrf_ex132.htm EX-13.2 4696
6 CONSOLIDATED FINANCIAL STATEMENTS betrf_ex991.htm   iXBRL EX-99.1 1336463
7 MANAGEMENT'S DISCUSSION AND ANALYSIS betrf_ex992.htm EX-99.2 225600
13 betrf_ex991img1.jpg GRAPHIC 2027
14 betrf_ex991img3.jpg GRAPHIC 1921
15 betrf_ex991img2.jpg GRAPHIC 2482
16 betrf_ex992img1.jpg GRAPHIC 4275
  Complete submission text file 0001477932-24-003392.txt   9261422

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA betrf-20240131.xsd EX-101.SCH 157637
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE betrf-20240131_lab.xml EX-101.LAB 501312
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE betrf-20240131_cal.xml EX-101.CAL 68921
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE betrf-20240131_pre.xml EX-101.PRE 457758
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE betrf-20240131_def.xml EX-101.DEF 279829
124 EXTRACTED XBRL INSTANCE DOCUMENT betrf_20f_htm.xml XML 1743804
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 438-884-8841
BetterLife Pharma Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 20-F | Act: 34 | File No.: 333-161157 | Film No.: 241006245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)